SFX by Ex Libris Inc.

Title:	Age-related remodelling of oesophageal epithelia by mutated cancer drivers
Source:	Nature [0028-0836] Akira Yokoyama, Nobuyuki yr:2019

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ryu, S. "The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging." Immunity. 55.9: 1609-4294967295.
description	2.	"The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis." Gut. 66.3: 399-410.
description	3.	Jones, Maria H. "Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization andÂ fieldÂ change." Nature Cell Biology 16.6 (2014): 615-622.
description	4.	Singal, Amit G. "International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma." Gastroenterology : official journal of the American Gastroenterological Association. 2572-2584.
description	5.	"PWE-177 The functional relevance of toll-like receptor 4 mutations in oesophageal adenocarcinoma." Gut. 64.Suppl 1.
description	6.	Kurauti, Mirian A. "Hyperinsulinemia is associated with increasing insulin secretion but not with decreasing insulin clearance in an age-related metabolic dysfunction mice model." Journal of cellular physiology. 234.6: 9802-9809.
description	7.	Ge, Phillip S. "Treatment of Patients with Cirrhosis." The New England Journal of Medicine 375.8 (2016): 767-777.
description	8.	Bonfanti, P. "Lineage potential, plasticity and environmental reprogramming of epithelial stem/progenitor cells." Biochemical Society transactions 42.3 (2014): 637-644.
description	9.	Ying, Y. "Targeted Deletion of p53 in the Proximal Tubule Prevents Ischemic Renal Injury." Journal of the American Society of Nephrology 25.12 (2014): 2707-2716.
description	10.	Fortini, M. "Notch Signaling: The Core Pathway and Its Posttranslational Regulation." Developmental cell 16.5 (2009): 633-647.
description	11.	Stenina, O. "MET orchestrates cancer and blood coagulation." Nature medicine 11.4 (2005): 376-377.
description	12.	Schrier, Robert W. "Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome." International Journal of Nephrology 2015 (2015): 975934-9.
description	13.	Ellul, Mark A. "Hepatic encephalopathy due to liver cirrhosis." BMJ. British medical journal 351.8021 (2015): 26-.
description	14.	Runyon, Bruce A. "Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012." Hepatology 57.4 (2013): 1651-1653.
description	15.	Bajaj, Jasmohan S. "The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers." The American journal of gastroenterology 106.9 (2011): 1646-1653.
description	16.	Bernardi, M. "Optimum use of diuretics in managing ascites in patients with cirrhosis." Gut 59.01 (2010): 10-11.
description	17.	Boccaccio, C. "The MET oncogene drives a genetic programme linking cancer to haemostasis." Nature 434.7031 (2005): 396-400.
description	18.	"Gene mutations linked to oesophageal adenocarcinoma." The Lancet oncology. 14.6.
description	19.	Linkermann, A. "Regulated Cell Death in AKI." Journal of the American Society of Nephrology 25.12 (2014): 2689-2701.
description	20.	Luo, Y. "Modeling induced pluripotent stem cells from fibroblasts of Duchenne muscular dystrophy patients." International journal of neuroscience 124.1 (2013): 1-21.